title: A balloon-expandable intravascular stent for obliterating experimental aortic dissection.
abstract: Acute aortic dissection is a life-threatening condition. Aggressive hypotensive drug therapy is the initial treatment of choice, although emergent surgical intervention is often warranted. We evaluated the efficacy of a balloon-expandable intravascular stent for the internal obliteration of aortic dissection. It is a flexible, continuous, complex coil cut to the length needed at the time of insertion. It can be positioned in curved vessels, including the aortic arch. The stent was inserted in the thoracic and abdominal aorta of 12 dogs (group I). Six weeks after implantation the dogs underwent angiography and the stents were explanted for light and scanning electron microscopy. There were no instances of stent migration or change in configuration. The aortas did not rupture. All branch vessels remained patent. Light and scanning electron microscopy illustrated neointimal incorporation into the vascular wall except at orifices. Thoracic dissections were created surgically in an additional 24 mongrel dogs. Twelve dogs received stents immediately after creation of the dissection (group II). All 12 dissections were obliterated. Twelve dogs were allowed to recover after creation of the dissection to observe the natural history of that lesion (group III). Within 1 week, in group III, there were three deaths because of aortic rupture; eight dissections persisted, and one resealed spontaneously. Stents were placed in the eight persistent dissections. All eight dissections were obliterated. In both groups, after 6 weeks of stent placement, aortography was repeated, and stents were explanted for light and scanning electron microscopy. There were no instances of rupture. All branch vessels remained patent with no evidence of thrombosis. We conclude that because of its unique characteristics, the stent effectively obliterates the false lumen of experimental acute aortic dissections without occlusing side branches, damaging the aorta, or inducing thrombosis.
authors.affiliation: Division of Vascular Surgery, Newark Beth Israel Medical Center, NJ 07112.
authors.forename: M S
authors.initials: MS
authors.lastname: Trent
authors.forename: V
authors.initials: V
authors.lastname: Parsonnet
authors.forename: R
authors.initials: R
authors.lastname: Shoenfeld
authors.forename: B J
authors.initials: BJ
authors.lastname: Brener
authors.forename: D E
authors.initials: DE
authors.lastname: Eisenbud
authors.forename: A S
authors.initials: AS
authors.lastname: Novick
authors.forename: A Y
authors.initials: AY
authors.lastname: Campbell
authors.forename: M
authors.initials: M
authors.lastname: Ferrara-Ryan
authors.forename: A
authors.initials: A
authors.lastname: Villanueva
mesh_terms: D000784:Aortic Dissection / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy*; D000818:Animals; D001011:Aorta / Q000648:ultrastructure; D001014:Aortic Aneurysm / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy*; D001672:Biocompatible Materials; D002404:Catheterization / Q000295:instrumentation / Q000379:methods*; D004285:Dogs; D008855:Microscopy, Electron, Scanning; D011859:Radiography; D015607:Stents
chemical_list: D001672:Biocompatible Materials